drugset / Trial / NCT02855658
Modulation of Immunity-related Gene Expression Under the Chinese Herbal Formula SS-1 Treatment for Sjögren's Syndrome
Phase 2
Unknown
90 enrolled
China Medical University Hospital
Chang Gung Memorial Hospital · collabChina Medical University, China · collabNational Research Program for Biopharmaceuticals, Taiwan · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
To evaluate the modulation of immunity-related gene expression for the Sjögren's syndrome under Chinese herbal medicine (SS-1) treatment.
Timeline
- Start
- 2014-02
- Primary completion
- 2016-10
- Completion
- 2017-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SS-1 | Cell therapy | 6 g | Oral |